Primary Record
Ginsenoside Re
- In stock
- 9,705 g
- Purity
- 99.2 %
- CAS
- 52286-59-6
Compound Identifiers & Properties
- CAS
- 52286-59-6
- PubChem CID
- 441921
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5[C@](C)(CCC=C(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)[C@@]7([C@@H]3C([C@H](CC7)O)(C)C)C)C)CO)O)O)O)O)O
- Canonical SMILES
- CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C
Names & Synonyms
- Ginsenoside Re
- Ginsenoside B2
- Panaxoside RE
- ginsenoside-Re
- Sanchinoside Re
- Chikusetsusaponin IVc
- 52286-59-6
- GinsenosideRe
- panaxsaponin Re
- Ginsenoside Rd
- Polyphyllin H
- Gypenoside VIII
- ginsenoside-Re standard
- RefChem:37695
- (20S)-ginsenoside Re
- 20(S)-ginsenoside Re
- AC1L9BXK
- 46F3R0BL3I
- UNII-46F3R0BL3I
- Ginsenoside Re (Standard)
- MFCD00133369
- CHEMBL510095
- PWAOOJDMFUQOKB-WCZZMFLVSA-N
- DTXSID801317298
- CHEBI:77148
- NSC 308877
- NSC-308877
- SCHEMBL669738
- CTK8F0918
- EINECS 257-814-6
- HY-N0044R
- WLZ4722
- C48H82O18
- DTXCID201747118
- GLXC-13358
- EX-A6794
- HY-N0044
- MSK40093
- Ginsenoside Re, 97% - 5MG 5mg
- BDBM50378779
- CID441921
- NP6988
- s3811
- AKOS025310861
- ZINC242620164
- ACN-035581
- CCG-270589
- CID:441921
- CS-3838
- DB14815
- EBC-618394
- OG09285
- C48-H82-O18
- GINSENOSIDE RE (REFERENCE GRADE)
- NCGC00483098-01
- AC-33946
- J38.851C
- SID:53789984
- SY076028
- TR-036967
- FT-0626704
- FT-0777127
- G0551
- C08944
- Ginsenoside B2; Panaxoside Re; Sanchinoside Re
- 286G596
- A829010
- C049864
- 51542-56-4
- b-D-Glucopyranoside,(3b,6a,12b)-20-(b-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-
- Q27105064
- (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- Ginsenoside-Re from Panax ginseng (Korean ginseng) root
- 2-O-(6-Deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside
- Ginsenoside-Re from Panax ginseng (Korean ginseng) root, triterpenoid saponin
- (20S)-6alpha-(2-O-alpha-L-Rhamnopyranosyl-beta-D-glucopyranosyloxy)-20-(beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta-diol
- (20S)-6alpha-[2-O-(alpha-L-Rhamnopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
- (2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-((1S)-1,5-dimethyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)oxy-hex-4-enyl)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl)oxy-6-methyl-tetrahydropyran-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyhept-5-en-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy-6-methyloxane-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-6-methyl-tetrahydropyran-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2S)-6-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl]-hexadecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-5-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (3b,6a,12b)-20-(b-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside
- (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-20-(.BETA.-D-GLUCOPYRANOSYLOXY)-3,12-DIHYDROXYDAMMAR-24-EN-6-YL 2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-
- [20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxy-5alpha-dammar-24-en-6alpha-yl]2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- [20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-6alpha-yl]2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- [20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammara-24-ene-6alpha-yl]2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxy-5alpha-dammar-24-en-6alpha-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-6alpha-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 3beta,12beta-Dihydroxy-6alpha-[2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene
- 52705-93-8
- 6alpha-[2-O-(alpha-L-Rhamnopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
- beta-D-Glucopyranoside, (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-
- GINSENOSIDE RE (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
- GRE
- N/A
- ss-D-Glucopyranoside, (3ss,6a,12ss)-20-(ss-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-; (3ss,6a,12ss)-20-(ss-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-ss-D-glucopyranoside; Chikusetsusaponin IVc; Ginsenoside B2; Ginsenoside Re; NSC 308877; Notoginsenoside Re; Panaxoside Re; Sanchinoside Re